Study name |
Clinical effectiveness of frozen thawed embryo transfer compared to fresh embryo transfer |
Methods |
RCT Estimated enrolment: 800 |
Participants |
Women aged 18‐42 Inclusion criteria:
Exclusion criteria:
Women using donor eggs/donor sperm
Women undergoing pre‐implantation genetic diagnosis
Women with abnormal uterine cavity shown on HSG or saline infusion sonogram
Women with hydrosalpinges shown on scanning and not treated
Women with excessive ovarian response at risk of OHSS where elective freeze is already planned
Women with serum progesterone level on day of hCG > 1.5 ng/mL or 5 nmol/L
Women whose embryos have previously not survived freeze‐thawing
Fresh transfer is planned, e.g. women with endometriosis or adenomyosis who have received prolonged down‐regulation
Only FET is planned, e.g. women receiving ovarian stimulation regimens that may adversely impact the endometrium
|
Interventions |
Intervention: fresh ET will not be undertaken in this group. Embryos will be frozen by vitrification or slow freezing at cleavage or blastocyst stage according to standard agreed local protocols. Women will be contacted after 4 weeks and arrangements made for FET. Control: women allocated to the control arm will either undergo fresh ET at cleavage stage or extended culture and transfer at blastocyst stage according to local policy. A maximum of 2 embryos or blastocysts will be replaced according to the standard protocol under transabdominal ultrasound guidance. Luteal‐phase support is given according to local protocols. |
Outcomes |
cLBR: within 6 months of ovarian stimulation from the fresh and frozen‐thawed ET
Live birth: a baby born alive after 20 weeks' gestation
Miscarriage: miscarriage before 20 weeks' gestation
Clinical pregnancy: presence of at least 1 gestational sac on ultrasound at 6 weeks
Ovarian hyperstimulation: classified according to Royal College of Obstetrics and Gynaecology in the United Kingdom
Complications of pregnancy
|
Starting date |
October 2015 |
Contact information |
Ernest HY Ng: nghye@hku.hk |
Notes |
clinicaltrials.gov/ct2/show/record/NCT02570386 |